Company Profile (AI Text)
Name: NLC - NLC Health Ventures
Canonical URL: https://wefunder.com/nlc.health
Updated at: 2026-06-04T05:02:55Z

Tagline: The most active early-stage healthcare investor
Elevator pitch: The project owner is a healthtech venture builder. They spin-out technologies from research, academic and corporate institutes and build them into commercial ventures (commonly known as ‘companies’). The project owner founds every venture they build (100+ since 2015) and actively supports them in reaching the market as soon as possible. The project owner also acts as the fund manager of captive funds that invest in all the ventures that the project owner builds. The ultimate goal is to bring impactful technologies to patients that can improve, or save, their lives, as multiple of project owner’s ventures already did. Once the project owner has supported the ventures in becoming mature and established companies, the project owner sells them to big international corporations, financial buyers (e.g. a venture capital or private equity fund), or the project owner may decide to list the venture on a public stock-exchange (initial public offering or IPO).

Key claims:
- Total raised on Wefunder: 392900 | citation: https://wefunder.com/nlc.health#claim-total-raised
- Total investors: 106 | citation: https://wefunder.com/nlc.health#claim-total-investors

Verified facts:
- Total raised on Wefunder: 392900 | observed_at: 2026-06-04T05:02:55Z | expires_at: 2026-06-05T05:02:55Z
- Total investors: 106 | observed_at: 2026-06-04T05:02:55Z | expires_at: 2026-06-05T05:02:55Z

Computed metrics:
- total_amount_raised: 392900
- total_investors: 106
- team_size: 3
- featured_investor_count: 7
- faq_count: 5
- recent_post_count: 0

Quick facts:
- Serious impact: impacted the lives of >120k patients so far, targeting improving >500M lives by 2030 | citation: https://wefunder.com/nlc.health#claim-fact-1
- Europe's most active early-stage healthtech investor according to Financial Times' Sifted | citation: https://wefunder.com/nlc.health#claim-fact-2
- Proven track record: already raised >€100M for our companies and generated profitable exits | citation: https://wefunder.com/nlc.health#claim-fact-3
- Strong team: dedicated team of 80+ (healthtech) professionals | citation: https://wefunder.com/nlc.health#claim-fact-4
- Inspiring network: 3,000+ investors, scientists, clinicians, universities and medical centers | citation: https://wefunder.com/nlc.health#claim-fact-5
- Strong partnerships: Medtronic, Mayo Clinic, Oxford, B.Braun, Charité, Stryker and more | citation: https://wefunder.com/nlc.health#claim-fact-6
- Founded >100 companies to date, meaning high diversification, lower risk. | citation: https://wefunder.com/nlc.health#claim-fact-7
- Ready for growth: scalable platform with extraordinary unit-economics (MM: ~7.0x, incl. failures) | citation: https://wefunder.com/nlc.health#claim-fact-8

FAQ:
- Q: What is the typical deal structure for one of these companies? How much do you invest and what percent ownership do you have? I'm also wondering what the total value of all the stakes you have of each of the companies is using the most recent fundraising round valuation and if...
  A: Hi Isaac, Thanks for the questions and your interest in NLC! Please find some answers below: What is the typical deal structure for one of these companies? Our ventures are typically set up as private limited liability structure companies with 1 class of shares. How much do you invest and what percent ownership do you have? At the start, NLC is the founder/entrepreneur/initiator. NLC recruits an entrepreneurial CEO (and sometimes 1-2 other key staff members) offering them a milestone-based eq...
- Q: What stake do you own in the companies you accelerate? What is the Net Asset Value of your current stake in the portfolio companies as of Dec 31, 2022?
  A: Hi Michael, Thanks for the question, we will add the response also to the main page, but see below as well: At the start, NLC is the founder/entrepreneur/initiator. NLC recruits an entrepreneurial CEO (and sometimes 1-2 other key staff members) offering them a milestone-based equity incentive scheme. Depending on whether the IP owner wants a royalty agreement or an equity stake in the company, NLC typically starts with something like 70% of the equity (the rest allocated to CEO/team and, if a...
- Q: As Isaac has noted. The deal terms are not clear
  A: Hi Noah, Thanks for the feedback, we will update our page a bit with the input from the questions below. Are there any other questions you have that we could answer for you? Also feel free to join our Q&A sessions: https://share-eu1.hsforms.com/19H7YHVfEQCaue_fVQodipwfflyc?utm_campaign=WeFunderNLC&utm_source=WeFunder%20page&utm_medium=link%20to%20Q%26A%20session%20form best regards, BA
- Q: Hello, I believe that diversification in asset is resulting to reduce the risk in investment . what is the exit strategy? Is there any company failed and became delisted? Do you intend to pay dividends upon exit ?
  A: Hi Alghamdi, Indeed the great level of diversification in the NLC portfolio substantially reduces the risk. The exit strategy for individual ventures will in most cases be via M&A to a strategic healthtech corporate. In some cases, we also expect a sale to private equity or even an IPO. In the early stage we operate in, there will always be companies that fail. To date, NLC has built 118 companies, with 84 active in the portfolio and 1 full exit (8 partial exits). 32 companies have been d...
- Q: What is the ultimate deadline to invest (assumed the € 11.7 mln goal will not be reached) ?
  A: Hi Vincent, we expect to close the Wefunder campaign at the beginning of Q1 2024, but it will depend on a variety of factors such as the amount raised and perceived interest. best regards, BA